16.2 Biomedical Therapy Notes
16.2 Biomedical Therapy
Overview of Biomedical Therapy Options
Biomedical therapy refers to treatments focusing on biological or physiological explanations for mental illness, primarily targeting the brain.
Early historical theories related to mental illness, although discredited, serve as critical touchpoints in the evolution of modern treatments.
Historical Context
Hippocrates and the Theory of Humors
Believed that mental illnesses were caused by an imbalance of four bodily fluids (humors): blood, black bile, yellow bile, and phlegm.
Too much black bile was associated with depression; too much blood with aggression and mania.
Treatments included exercise, dietary changes, and alterations in sexual behavior.
Trephination
An ancient practice involving drilling holes into the skull, believed to release demons or evil spirits.
Evidence dates back up to 12,000 years with findings from various locations like East Africa, South America, and France.
Modern Biomedical Treatments
Electroconvulsive Therapy (ECT)
A treatment historically associated with shock therapy aiming to induce controlled seizures to treat severe depression.
Initial therapy methods were considered brutal, involving insulin shock or hydrotherapy.
Evolution of ECT:
ECT has undergone significant modifications to become a safer treatment environment.
Early treatments resulted in severe side effects, including memory loss and sometimes were not therapeutically beneficial.
Currently, ECT is used as a last resort for severe long-term depression or bipolar disorder when other treatments have failed.
Modern ECT involves careful monitoring and sedation for patient safety, with sessions typically administered three times a week for two weeks or longer.
Reliable side effects include temporary loss of recent memories.
Possible Mechanism of Action: ECT may support brain plasticity by promoting new growth and eliminating unused neural synapses
ECT is effective but still considered a last resort due to remaining unknowns about its mechanisms (Boukert et al., 2014; Slate et al., 2017).
Therapeutic Drug Options
The pharmaceutical industry has significantly contributed to mental health treatment through psychoactive drugs.
Key Concerns:
Reliance on drugs vs. exploring therapeutic options, ethicality of over-prescription, and understanding the placebo effect in treatment efficacy.
Classes of Psychoactive Drugs
Antidepressants
Monoamine Oxidase Inhibitors (MAOIs):
Discovered in the 1950s; block breakdown of serotonin, norepinephrine, and dopamine, increasing their availability and thereby boosting mood.
Tricyclic Antidepressants:
Invented in the late 1950s to 1960s; block neurotransmitter reuptake, thus uplifting brain levels of serotonin and norepinephrine.
Common side effects include weight gain, constipation, dry mouth, and dizziness.
Selective Serotonin Reuptake Inhibitors (SSRIs):
Developed in the late 1980s; work solely on serotonin reuptake and are currently the most popular antidepressant class.
Examples: fluoxetine and paroxetine.
New Generation Options:
Serotonin-norepinephrine reuptake inhibitors (SNRIs) and ketamine are recent advancements for treating those resistant to SSRIs.
Anti-Anxiety Drugs (Anxiolytics)
Designed to alleviate excessive worry and anxiety.
Main drugs: benzodiazepines such as chlordiazepoxide, diazepam, and alprazolam enhance GABA activity.
While effective short-term, these drugs pose risks of addiction.
Stimulants
Commonly used for ADHD; improve attention and concentration by enhancing the release of dopamine and norepinephrine.
Significant historical examples: amphetamine and methylphenidate (Ritalin).
Antipsychotics
Developed for schizophrenia; categorized into typical (e.g., chlorpromazine) and atypical drugs that may also block serotonin receptors.
Unwanted side effects include movement disorders and weight gain, though atypical antipsychotics generally yield fewer adverse effects.
Mood Stabilizers
Used primarily for bipolar disorder to easily manage mood swings.
Lithium, the first mood stabilizer, impacts sodium transport in neurons, although its efficacy and mechanisms are still partially understood.
Anticonvulsants (e.g., valproic acid, lamotrigine) are also effective mood stabilizers.
Controversies Surrounding Biomedical Therapies
The increasing prescription rates for antidepressants spark debates regarding over-reliance, efficacy, the placebo effect, and the stigma attached to their use.
Prescription numbers for antidepressants grew from 18.4 million in 1998 to 70.9 million in 2018 (Bagoics et al., 2021).
Some studies suggest that several well-known antidepressants did not perform significantly better than placebos (Kirsch et al., 2008).
Issues are raised about the potential for over-medication, particularly when environmental factors might contribute to mental states.
Additional Biomedical Approaches
EMDR (Eye Movement Desensitization and Reprocessing)
Formulated for PTSD, the therapy helps reshape memory storage of traumatic events through guided eye movements, yet its efficacy remains debated amidst mixed study results.
Biofeedback
Aims to provide control over involuntary functions (e.g., heart rate) by measuring physiological responses; encourages relaxation techniques to manage stress and mood.
Light Therapy (Phototherapy)
Common in treating Seasonal Affective Disorder (SAD) by mimicking natural light to boost serotonin and help regulate circadian rhythms.
Transcranial Magnetic Stimulation (TMS)
Non-invasive treatment delivering magnetic pulses to the brain’s cortex to potentially improve mood; used in treatment-resistant depression and OCD.
Deep Brain Stimulation (DBS)
Involves surgically implanting electrodes to stimulate specific brain regions; regarded as a last resort for severe depression.
Exercise
Questionable effects: Some studies show improvement in anxiety and mood, while others suggest increased anxiety levels can occur.
Recommended exercises include rhythmic and aerobic activities, typically low to moderate intensity, performed regularly (3x a week).
Effectiveness of Biomedical Therapies
Varying effectiveness examples:
ECT yields rapid effects for depression yet benefits are transient (Tokutsu et al., 2013).
Lithium's long-term efficacy in bipolar treatment is inconsistent (Karney & Goodwin).
Antipsychotic effectiveness is mainly for positive symptoms (e.g., hallucinations), but less so for negative symptoms (e.g., emotional lack).
Antidepressants’ effectiveness relative to placebos raises concerns about reliance on pharmacotherapy alone.
Newer methods like TMS and DBS are promising yet pose implementation complexities.
Integration of biomedical therapies with psychotherapeutic practices has widespread support amongst professionals, advocating a combined treatment approach for optimal outcomes.